Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) EBT (2018 - 2026)

Viemed Healthcare filings provide 8 years of EBT readings, the most recent being $8.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 26.99% to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.8 million, a 34.61% increase, with the full-year FY2025 number at $21.8 million, up 34.61% from a year prior.
  • EBT hit $8.0 million in Q4 2025 for Viemed Healthcare, up from $5.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.0 million in Q4 2025 to a low of $1.4 million in Q2 2022.
  • Median EBT over the past 5 years was $3.4 million (2021), compared with a mean of $3.7 million.
  • Biggest five-year swings in EBT: tumbled 77.97% in 2021 and later soared 180.54% in 2023.
  • Viemed Healthcare's EBT stood at $5.1 million in 2021, then decreased by 29.1% to $3.6 million in 2022, then soared by 41.63% to $5.1 million in 2023, then rose by 24.21% to $6.3 million in 2024, then increased by 26.99% to $8.0 million in 2025.
  • The last three reported values for EBT were $8.0 million (Q4 2025), $5.1 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.